In January, Swiss firms contributed US$45.29 million in foreign direct investment (FDI) in Vietnam across 1 new project, according to data from Vietnam’s Ministry of Planning and Investment. This represents an increase of US$42.48 million compared to December, which saw US$2.81 million in registered capital with 1 new project.
Swiss investments accounted for 1.04 percent of total FDI in January, up from 0.04 percent in December.
Switzerland has become an important source of foreign direct investment (FDI) in Vietnam, particularly in sectors such as banking, finance, pharmaceuticals, chemicals, machinery, and high-tech industries. The strong economic ties between the two countries are supported by Switzerland’s role as a global financial hub and its companies’ interest in expanding operations in Southeast Asia. Vietnam’s growing economy, strategic location, competitive workforce, and open market policies make it an attractive destination for Swiss investors.
One of the key sectors for Swiss FDI in Vietnam is the pharmaceutical and healthcare industry. Swiss pharmaceutical companies, such as Novartis and Roche, have established a strong presence in Vietnam, capitalising on the country’s growing healthcare needs, a rising middle class, and increasing demand for high-quality medical products and services. Swiss companies also play a significant role in the chemicals and machinery sectors, contributing to Vietnam’s industrialisation and modernization efforts.
In addition to these sectors, Switzerland has made considerable investments in Vietnam’s finance and banking industries, with Swiss banks and financial institutions helping to strengthen the financial infrastructure in Vietnam. Swiss-based firms have also been active in the agriculture and food processing sectors, as Vietnam’s agricultural products gain global recognition, and demand for high-quality food and beverage products increases.
See also: How to Start a Business in Vietnam